共 38 条
Microbiome-Linked Crosstalk in the Gastrointestinal Exposome towards Host Health and Disease
被引:15
|作者:
Moon, Yuseok
[1
,2
,3
,4
]
机构:
[1] Pusan Natl Univ, Dept Biomed Sci, Lab Mucosal Exposome & Biomodulat, Sch Med, Yangsan, South Korea
[2] Pusan Natl Univ, Res Inst Basic Sci, Busan, South Korea
[3] Pusan Natl Univ, Med Res Inst, Busan, South Korea
[4] Immunoregulatory Therapeut Grp Brain Busan 21 Pro, Busan, South Korea
基金:
新加坡国家研究基金会;
关键词:
Gastrointestinal exposome;
Microbiota;
Gastrointestinal immunity and inflammation;
Xenobiotic metabolism;
D O I:
10.5223/pghn.2016.19.4.221
中图分类号:
R72 [儿科学];
学科分类号:
100202 ;
摘要:
The gastrointestinal exposome represents the integration of all xenobiotic components and host-derived endogenous components affecting the host health, disease progression and ultimately clinical outcomes during the lifespan. The human gut microbiome as a dynamic exposome of commensalism continuously interacts with other exogenous exposome as well as host sentineling components including the immune and neuroendocrine circuit. The composition and diversity of the microbiome are established on the basis of the luminal environment (physical, chemical and biological exposome) and host surveillance at each part of the gastrointestinal lining. Whereas the chemical exposome derived from nutrients and other xenobiotics can influence the dynamics of microbiome community (the stability, diversity, or resilience), the microbiomes reciprocally alter the bioavailability and activities of the chemical exposome in the mucosa. In particular, xenobiotic metabolites by the gut microbial enzymes can be either beneficial or detrimental to the host health although xenobiotics can alter the composition and diversity of the gut microbiome. The integration of the mucosal crosstalk in the exposome determines the fate of microbiome community and host response to the etiologic factors of disease. Therefore, the network between microbiome and other mucosal exposome would provide new insights into the clinical intervention against the mucosal or systemic disorders via regulation of the gut-associated immunological, metabolic, or neuroendocrine system.
引用
收藏
页码:221 / 228
页数:8
相关论文